Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea · Delayed Price · Currency is KRW

26,200

-250 (-0.95%)

Aug 3, 2026, 3:30 PM KST

Daihan Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	211,440	208,614	204,195	195,911	184,268	171,463
Revenue Growth	3.11%	2.16%	4.23%	6.32%	7.47%	3.24%
Gross Profit	63,085	64,445	69,407	65,312	59,812	55,682
Operating Income	29,815	31,186	38,081	35,795	32,968	29,068
Net Income	26,978	27,644	33,759	28,426	24,961	22,670
Earnings Per Share	4588.16	4701.33	5741.34	4834.41	4170.67	3778.40
EPS Growth	-18.59%	-18.11%	18.76%	15.92%	10.38%	30.43%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	98,660	89,535	77,237	104,359	97,607	96,415
Total Debt	48.4	13.26	29.03	-	6,500	23,517
Net Cash (Debt)	98,612	89,522	77,208	104,359	91,107	72,899
Net Cash Growth	-7.82%	15.95%	-26.02%	14.55%	24.98%	87.68%
Net Cash Per Share	16770.69	15224.79	13130.53	17748.21	15223.16	12149.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	26,068	25,604	35,643	38,860	28,999	40,617
Capital Expenditures	-22,944	-25,123	-15,801	-21,280	-8,621	-11,850
Free Cash Flow	3,124	481.53	19,841	17,580	20,378	28,767
Free Cash Flow Growth	-84.44%	-97.57%	12.86%	-13.73%	-29.16%	1.77%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	29.84%	30.89%	33.99%	33.34%	32.46%	32.48%
Operating Margin	14.10%	14.95%	18.65%	18.27%	17.89%	16.95%
Pretax Margin	15.20%	15.89%	20.73%	18.75%	18.15%	17.75%
Profit Margin	12.76%	13.25%	16.53%	14.51%	13.55%	13.22%
FCF Margin	1.48%	0.23%	9.72%	8.97%	11.06%	16.78%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.71	6.22	4.56	5.74	7.36	7.60
P/FCF Ratio	49.31	357.17	7.76	9.28	9.01	5.99
PS Ratio	0.73	0.82	0.75	0.83	1.00	1.00